文献速递创伤与烧伤复苏、休克与脓毒症呼吸衰竭与机械通气

创伤与失血性休克后缓激肽释放导致啮齿类动物肺肺泡渗漏

Bradykinin release following trauma and hemorrhagic shock causes pulmonary alveolar leak in a rodent model.
PubMed 文献 · J Trauma Acute Care Surg · 2023-06-14
一句话结论大鼠混合损伤模型显示,创伤/失血性休克通过缓激肽释放引起肺肺泡渗漏,B2拮抗剂HOE-140/艾替班特可抑制该渗漏。

该基础研究在大鼠组织损伤/失血性休克(TI/HS)模型中,验证缓激肽(BK)释放是否导致肺肺泡渗漏。体外实验显示BK受体B2拮抗剂HOE-140/艾替班特抑制BK启动的中性粒细胞氧化酶活性达85.0±5.3%(p<0.05)。TI/HS模型凝血激活(血浆凝血酶-抗凝血酶复合物升高,p<0.05),与对照相比肺肺泡渗漏显著增加(1.46±0.21% vs 0.36±0.10%,p=0.001),BALF总蛋白和CINC-1升高(p<0.05)。TI后给予艾替班特可显著抑制肺渗漏(p<0.002)和BALF CINC-1升高(p<0.05),但不影响总蛋白。作者认为该混合损伤模型引起全身止血系统激活和肺肺泡渗漏,可能由BK释放所致。

要点

  • 大鼠TI/HS模型出现显著肺肺泡渗漏:1.46±0.21% vs 对照0.36±0.10%(p=0.001)。
  • BK受体B2拮抗剂HOE-140/艾替班特在体外抑制BK启动的中性粒细胞氧化酶活性达85.0±5.3%(p<0.05)。
  • TI后给予艾替班特抑制肺渗漏(p<0.002)及BALF CINC-1升高(p<0.05),但不影响BALF总蛋白。
  • TI/HS模型血浆凝血酶-抗凝血酶复合物升高(p<0.05),提示全身凝血激活。
  • 肺内未见中性粒细胞隔离。

适用人群与场景

  • 大鼠组织损伤/失血性休克模型(TI/HS),以及体外分离的中性粒细胞(PMNs)。

处置流程与药物剂量

  • 体外:中性粒细胞先用特异性BK受体B2拮抗剂HOE-140/艾替班特预处理,再完成BK启动的PMN氧化酶检测。
  • 大鼠TI后给予艾替班特,观察对肺渗漏及BALF CINC-1的影响。

研究设计与关键结果

  • 研究类型:基础科学(动物实验与体外细胞实验)。
  • BK受体B2拮抗剂HOE-140/艾替班特抑制BK启动的PMN氧化酶达85.0±5.3%(p<0.05)。
  • TI/HS模型血浆凝血酶-抗凝血酶复合物升高(p<0.05),提示凝血激活。
  • 与对照相比,TI/HS大鼠肺肺泡渗漏显著增加:1.46±0.21% vs 0.36±0.10%(p=0.001),BALF总蛋白和CINC-1升高(p<0.05)。
  • TI后给予艾替班特显著抑制TI/icatibant/HS组肺渗漏(p<0.002)及BALF CINC-1升高(p<0.05),但不影响BALF总蛋白。
  • 肺内未见PMN隔离。

证据类型、等级与局限

  • 证据类型:基础科学(动物实验与体外实验)。
  • 证据等级:Original Article, Basic Science。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该混合损伤模型引起全身止血系统激活和肺肺泡渗漏,可能由BK释放所致。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhage accounts for 40% of the preventable death following severe injury. Activation of systemic coagulation produces bradykinin (BK), which may cause leak from the plasma to the extravascular space and to the tissues, which is part of the complex pathophysiology of trauma-induced end-organ injury. We hypothesize that BK, released during activation of coagulation in severe injury, induces pulmonary alveolar leak.

METHODS: Isolated neutrophils (PMNs) were pretreated with a specific BK receptor B2 antagonist HOE-140/icatibant and BK priming of the PMN oxidase was completed. Rats underwent tissue injury/hemorrhagic shock (TI/HS), TI/icatibant/HS, and controls (no injury). Evans blue dye was instilled, and the percentage leak from the plasma to the lung was calculated from the bronchoalveolar lavage fluid (BALF). CINC-1 and total protein were measured in the BALF, and myeloperoxidase was quantified in lung tissue.

RESULTS: The BK receptor B2 antagonist HOE140/icatibant inhibited (85.0 ± 5.3%) BK priming of the PMN oxidase ( p < 0.05). The TI/HS model caused activation of coagulation by increasing plasma thrombin-antithrombin complexes ( p < 0.05). Versus controls, the TI/HS rats had significant pulmonary alveolar leak: 1.46 ± 0.21% versus 0.36 ± 0.10% ( p = 0.001) and increased total protein and CINC-1 in the BALF ( p < 0.05). Icatibant given after the TI significantly inhibited lung leak and the increase in CINC-1 in the BALF from TI/icatibant/HS rats versus TI/HS ( p < 0.002 and p < 0.05) but not the total protein. There was no PMN sequestration in the lungs. Conclusions: This mixed injury model caused systemic activation of hemostasis and pulmonary alveolar leak likely due to BK release.

CONCLUSION: This mixed injury model caused systemic activation of hemostasis and pulmonary alveolar leak likely due to BK release.

LEVEL OF EVIDENCE: Original Article, Basic Science.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Eitel A, Moore EE, Kelher MR, et al. Bradykinin release following trauma and hemorrhagic shock causes pulmonary alveolar leak in a rodent model. J Trauma Acute Care Surg. 2023. PMID: 37314576. doi:10.1097/TA.0000000000003943

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。